scholarly journals Individualization of first line antiretroviral treatment with the use of therapeutic drug monitoring (TDM) in a resource limited settings.

2018 ◽  
Vol 73 ◽  
pp. 298-299
Author(s):  
P. Scibona ◽  
W. Belloso ◽  
M. de Paz Sierra ◽  
M. Sanchez
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Antiretroviral Treatment ◽  
Therapeutic Drug ◽  
First Line ◽  
Resource Limited Settings ◽  
Resource Limited

scholarly journals Therapeutic Drug Monitoring of Nevirapine in Resource‐Limited Settings

2008 ◽  
Vol 47 (10) ◽  
pp. 1339-1344 ◽  
Author(s):  
Rafaëlla F. A. L’homme ◽  
Eva P. Muro ◽  
Jacqueline A. H. Droste ◽  
Liselotte R. Wolters ◽  
Noor W. J. van Ewijk‐Beneken Kolmer ◽  
...  
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Resource Limited Settings ◽  
Resource Limited

scholarly journals Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay

2018 ◽  
Vol 62 (5) ◽  
Author(s):  
Katarina Niward ◽  
Linnea Ek Blom ◽  
Lina Davies Forsman ◽  
Judith Bruchfeld ◽  
Erik Eliasson ◽  
...  
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Plasma Levels ◽  
Treatment Initiation ◽  
Therapeutic Drug ◽  
Activity Assay ◽  
First Line ◽  
Resource Limited Settings ◽  
Drug Activity ◽  
Tb Treatment ◽  
Resource Limited

ABSTRACT The plasma tuberculosis drug activity (TDA) assay may be an alternative tool for therapeutic drug monitoring in resource-limited settings. In tuberculosis (TB) patients ( n = 30), TDA and plasma levels of first-line drugs were analyzed 2 h postdose, 2 weeks after treatment initiation. Patients with plasma levels of rifampin lower than 8 mg/liter had a significantly lower median TDA (1.40 versus 1.68, P = 0.0013). TDA may be used to identify TB patients with suboptimal rifampin levels during TB treatment.

Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring

2016 ◽  
Vol 72 (8) ◽  
pp. 905-916 ◽  
Author(s):  
Roger K. Verbeeck ◽  
Gunar Günther ◽  
Dan Kibuule ◽  
Christian Hunter ◽  
Tim W. Rennie
Keyword(s):  
Treatment Outcome ◽  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
First Line

scholarly journals Sub-therapeutic nevirapine concentration during antiretroviral treatment initiation among children living with HIV: Implications for therapeutic drug monitoring

PLoS ONE ◽  
2017 ◽  
Vol 12 (8) ◽  
pp. e0183080 ◽  
Author(s):  
Bindu Parachalil Gopalan ◽  
Kayur Mehta ◽  
Reena R. D'souza ◽  
Niharika Rajnala ◽  
Hemanth Kumar A. K. ◽  
...  
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Antiretroviral Treatment ◽  
Treatment Initiation ◽  
Therapeutic Drug ◽  
Living With Hiv ◽  
Nevirapine Concentration

The Advantages of Therapeutic Drug Monitoring in Patients Receiving Antiretroviral Treatment and Experiencing Medication-Related Problems

2013 ◽  
Vol 35 (1) ◽  
pp. 71-77 ◽  
Author(s):  
Joan A. Schoenenberger ◽  
Ana M. Aragones ◽  
Santiago M. Cano ◽  
Teresa Puig ◽  
Angela Castello ◽  
...  
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Antiretroviral Treatment ◽  
Therapeutic Drug

scholarly journals Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis

2019 ◽  
Vol 58 (11) ◽  
pp. 1445-1454 ◽  
Author(s):  
Antonia Morita I. Saktiawati ◽  
Marcel Harkema ◽  
Althaf Setyawan ◽  
Yanri W. Subronto ◽  
Sumardi ◽  
...  
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Optimal Sampling ◽  
Sampling Strategies ◽  
First Line
Sign in / Sign up

Export Citation Format

Share Document